{"id":"https://openalex.org/W3012736695","doi":null,"title":"A Novel Topical Retinoid for Acne: Trifarotene 50 \u03bcg/g Cream","display_name":"A Novel Topical Retinoid for Acne: Trifarotene 50 \u03bcg/g Cream","publication_year":2020,"publication_date":"2020-03-01","ids":{"openalex":"https://openalex.org/W3012736695","mag":"3012736695","pmid":"https://pubmed.ncbi.nlm.nih.gov/32196146"},"language":"en","primary_location":{"id":"pmid:32196146","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32196146","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Skin therapy letter","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5003840120","display_name":"Jerry K.L. Tan","orcid":"https://orcid.org/0000-0002-9624-4530","observed_orcids":["https://orcid.org/0000-0002-9624-4530"]},"institutions":[{"id":"https://openalex.org/I125749732","display_name":"Western University","ror":"https://ror.org/02grkyz14","country_code":"CA","type":"education","lineage":["https://openalex.org/I125749732"]},{"id":"https://openalex.org/I4210101092","display_name":"Windsor Clinical Research","ror":"https://ror.org/012kq8z96","country_code":"CA","type":"facility","lineage":["https://openalex.org/I4210101092"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Jerry Tan","raw_affiliation_strings":["Windsor Clinical Research Inc., Windsor, ON, Canada","Schulich School of Medicine and Dentistry, Western University, Windsor Campus, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Windsor Clinical Research Inc., Windsor, ON, Canada","institution_ids":["https://openalex.org/I4210101092"]},{"raw_affiliation_string":"Schulich School of Medicine and Dentistry, Western University, Windsor Campus, ON, Canada","institution_ids":["https://openalex.org/I125749732"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5077395564","display_name":"Maegan Miklas","orcid":"https://orcid.org/0000-0003-2203-8563","observed_orcids":["https://orcid.org/0000-0003-2203-8563"]},"institutions":[{"id":"https://openalex.org/I125749732","display_name":"Western University","ror":"https://ror.org/02grkyz14","country_code":"CA","type":"education","lineage":["https://openalex.org/I125749732"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Maegan Miklas","raw_affiliation_strings":["Schulich School of Medicine and Dentistry, Western University, Windsor Campus, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Schulich School of Medicine and Dentistry, Western University, Windsor Campus, ON, Canada","institution_ids":["https://openalex.org/I125749732"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.3935,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.59499079,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":95},"biblio":{"volume":"25","issue":"2","first_page":"1","last_page":"2"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11553","display_name":"Acne and Rosacea Treatments and Effects","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11013","display_name":"Skin Protection and Aging","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/trifarotene","display_name":"trifarotene","score":0.9179999828338623},{"id":"https://openalex.org/keywords/topical-retinoids","display_name":"topical retinoids","score":0.9369999766349792},{"id":"https://openalex.org/keywords/acne-vulgaris","display_name":"acne","score":0.9660000205039978},{"id":"https://openalex.org/keywords/retinoic-acid-receptor-gamma","display_name":"retinoic acid receptor gamma","score":0.9459999799728394},{"id":"https://openalex.org/keywords/facial-acne","display_name":"facial acne","score":0.6050000190734863},{"id":"https://openalex.org/keywords/truncal-acne","display_name":"truncal acne","score":0.9440000057220459},{"id":"https://openalex.org/keywords/lesion-count-reduction","display_name":"lesion count reduction","score":0.8489999771118164},{"id":"https://openalex.org/keywords/cutaneous-adverse-effects","display_name":"cutaneous adverse events","score":0.5019999742507935},{"id":"https://openalex.org/keywords/drug-safety-and-tolerability","display_name":"drug safety and tolerability","score":0.7950000166893005}],"concepts":[{"id":"https://openalex.org/C2777673923","wikidata":"https://www.wikidata.org/wiki/Q79928","display_name":"Acne","level":2,"score":0.9061903953552246},{"id":"https://openalex.org/C2777140388","wikidata":"https://www.wikidata.org/wiki/Q352348","display_name":"Adapalene","level":5,"score":0.833433985710144},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8312113285064697},{"id":"https://openalex.org/C2775954498","wikidata":"https://www.wikidata.org/wiki/Q420418","display_name":"Retinoid","level":4,"score":0.8201368451118469},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7745585441589355},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.6551748514175415},{"id":"https://openalex.org/C2779963572","wikidata":"https://www.wikidata.org/wiki/Q29417","display_name":"Tretinoin","level":4,"score":0.6427894830703735},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6097174882888794},{"id":"https://openalex.org/C2781121885","wikidata":"https://www.wikidata.org/wiki/Q425517","display_name":"Retinoic acid","level":3,"score":0.3397709131240845},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.2962087392807007},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.06270834803581238},{"id":"https://openalex.org/C44228677","wikidata":"https://www.wikidata.org/wiki/Q181898","display_name":"Polymerization","level":3,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C521977710","wikidata":"https://www.wikidata.org/wiki/Q81163","display_name":"Polymer","level":2,"score":0.0},{"id":"https://openalex.org/C2778885487","wikidata":"https://www.wikidata.org/wiki/Q411424","display_name":"Benzoyl peroxide","level":4,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C178790620","wikidata":"https://www.wikidata.org/wiki/Q11351","display_name":"Organic chemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D000152","descriptor_name":"Acne Vulgaris","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D000279","descriptor_name":"Administration, Cutaneous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D003879","descriptor_name":"Dermatologic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D012176","descriptor_name":"Retinoids","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016032","descriptor_name":"Randomized Controlled Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017326","descriptor_name":"Clinical Trials, Phase III as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:32196146","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32196146","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Skin therapy letter","raw_type":"Journal Article"},{"id":"mag:3012736695","doi":null,"is_oa":false,"landing_page_url":"https://europepmc.org/article/MED/32196146","pdf_url":null,"source":{"id":"https://openalex.org/S4306530114","display_name":"Skin therapy letter","issn_l":"1201-5989","issn":["1201-5989","1911-7663"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","medline","poland-40","russia-white-list-1"],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Skin therapy letter","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4400274094","https://openalex.org/W4396850802","https://openalex.org/W3023223971","https://openalex.org/W3110017495","https://openalex.org/W2917427088","https://openalex.org/W3184735587","https://openalex.org/W3195861351","https://openalex.org/W7117965317","https://openalex.org/W2987852697","https://openalex.org/W4327587656"],"abstract_inverted_index":{"Trifarotene":[0],"50":[1,114],"\u03bcg/g":[2,115],"cream":[3,116],"is":[4],"a":[5,66],"fourth":[6],"generation":[7],"topical":[8,29],"retinoid":[9],"with":[10,75],"retinoic":[11],"acid":[12],"receptor":[13],"gamma":[14],"selectivity.":[15],"It":[16],"was":[17],"recently":[18],"approved":[19],"by":[20],"the":[21,28,87,100,109],"US":[22],"FDA":[23],"and":[24,33,40,56,65,73,94],"Health":[25],"Canada":[26],"for":[27,36,86,120],"treatment":[30],"of":[31,91,112],"facial":[32],"truncal":[34],"acne":[35,58],"those":[37],"aged":[38],"9":[39],"older":[41],"based":[42],"on":[43],"two":[44],"identically":[45],"designed":[46],"phase":[47],"3":[48],"trials":[49],"demonstrating":[50],"superiority":[51],"in":[52,80],"lesion":[53],"count":[54],"reduction":[55],"global":[57],"improvement":[59],"compared":[60],"to":[61,96,107],"vehicle.":[62],"These":[63,89],"studies":[64,103],"1":[67],"year":[68],"study":[69],"also":[70],"demonstrated":[71],"safety":[72],"tolerability":[74],"cutaneous":[76],"adverse":[77],"events":[78],"developing":[79],"an":[81],"anticipated":[82],"timeframe":[83],"(1":[84],"week)":[85],"face.":[88],"were":[90],"lesser":[92],"degree":[93],"tended":[95],"develop":[97],"later":[98],"at":[99],"trunk.":[101],"Future":[102],"will":[104],"be":[105],"required":[106],"evaluate":[108],"comparative":[110],"efficacy":[111],"trifarotene":[113],"against":[117],"other":[118],"treatments":[119],"acne.":[121]},"counts_by_year":[{"year":2021,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-03-27T00:00:00"}